Sign in
Active, not recruitingNo phase

Sensory Motor Transformations in Human Cortex

Key facts

Who runs it
Richard A. Andersen, PhD
Where
Aurora, Downey, Los Angeles, and Pasadena, United StatesSee the 4 sites
Trial code
Status
Active, not recruiting
People taking part
5 people, planned
Started
1 Nov 2013
Expected to end
31 Jan 2029
Type of study
Interventional
Treatments tested
  • Neural Prosthetic System 2 (NPS2)
Record updated
23 October 2026

Who can take part

Age
22 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 34 criteriaShow less

Who can take part

  • High cervical spinal lesion
  • Age 22-65
  • Able to provide informed consent
  • Able to understand and comply with instructions in English
  • Communicate via speech
  • Surgical clearance
  • Life expectancy greater than 12 months
  • Travel up to 60 miles to study locations up to five days per week
  • Caregiver monitor for surgical site complications and behavioral changes on a daily basis
  • Psychosocial support system

Who cannot take part

  • Previous neurosurgical history affecting parietal lobe function
  • Prior cranioplasty
  • Chronic oral or intravenous use of steroids or immunosuppressive therapy
  • Drug or alcohol dependence
  • Implanted deep brain stimulator (DBS), DBS leads, or cochlear implant
  • Intellectual impairment
  • Psychotic illness or chronic psychiatric disorder, including major depression if untreated
  • Active infection or unexplained fever
  • HIV or AIDS infection
  • Active cancer or chemotherapy
  • Diabetes
  • History of seizure
  • Medical conditions contraindicating surgery and chronic implantation of a medical device
  • Implanted Cardiac Defibrillator, Pacemaker, vagal nerve stimulator, or spinal cord stimulator
  • Presence of memory problems
  • Poor visual acuity
  • Pregnancy
  • Scalp lesions or skin breakdown
  • Autonomic dysreflexia
  • Implanted hydrocephalus shunt
  • Unable to undergo MRI or anticipated need for MRI during study
  • Nursing an infant or unwilling to bottle-feed infant
  • Suicidal ideation
  • Planning to become pregnant, or unwilling to use adequate birth control

Where in United States

  • University of Colorado Anschutz Medical CampusAurora, United States
  • Rancho Los Amigos National Rehabilitation CenterDowney, United States
  • University of Southern CaliforniaLos Angeles, United States
  • Richard AndersenPasadena, United States

About the trial

What the trial wants to find out

This research study is being conducted to develop a brain controlled medical device, called a brain-machine interface. The device will provide people with a spinal cord injury some ability to control an external device such as a computer cursor or robotic limb by using their thoughts along with sensory feedback.

Read full original descriptionShow less

Development of a brain-machine interface is very difficult and currently only limited technology exists in this area of neuroscience. Other studies have shown that people with high spinal cord injury still have intact brain areas capable of planning movements and grasps, but are not able to execute the movement plans. The device in this study involves implanting very fine recording electrodes into areas of the brain that are known to create arm movement plans and provide hand grasping information and sense feeling in the hand and fingers. These movement and grasp plans would then normally be sent to other regions of the brain to execute the actual movements. By tying into those pathways and sending the movement plan signals to a computer instead, the investigators can translate the movement plans into actual movements by a computer cursor or robotic limb.

A key part of this study is to electrically stimulate the brain by introducing a small amount of electrical current into the electrodes in the sensory area of the brain. This will result in the sensation of touch in the hand and/or fingers. This stimulation to the brain will occur when the robotic limb touches the object, thereby allowing the brain to "feel" what the robotic arm is touching.

The device being used in this study is called the Neuroport Array and is surgically implanted in the brain. This device and the implantation procedure are experimental which means that it has not been approved by the Food and Drug Administration (FDA). One Neuroport Array consists of a small grid of electrodes that will be implanted in brain tissue and a small cable that runs from the electrode grid to a small hourglass-shaped pedestal. This pedestal is designed to be attached to the skull and protrude through the scalp to allow for connection with the computer equipment. The top portion of the pedestal has a protective cover that will be in place when the pedestal is not in use. The top of this pedestal and its protective cover will be visible on the outside of the head. Three Neuroport Arrays and pedestals will be implanted in this study so three of these protective covers will be visible outside of the head. It will be possible to cover these exposed portions of the device with a hat or scarf.

The investigators hope to learn how safe and effective the Neuroport array plus stimulation is in controlling computer generated images and real world objects, such as a robotic arm, using imagined movements of the arms and hands.

The group in the trial

  • Neural Prosthetic System 2Treatment being tested

    The Neural Prosthetic System 2 consists of three Neuroport Arrays, which are described in detail in the intervention description. Two of the three Neuroport Arrays are inserted into the posterior parietal cortex, an area of the brain used in reach and grasp planning. The third Neuroport Array is inserted into somatosensory cortex, specifically S1 which represents sensory feedback for the hand and fingers. The arrays are inserted and the percutaneous pedestal is attached to the skull during a surgical procedure. Following surgical recovery the subject will participate in study sessions 3-5 times per week in which they will learn to control an end effector by thought augmented with sensory feedback via intracortical microstimulation. They will then use the end effector to perform various reach and grasp tasks.

    Treatment: Neural Prosthetic System 2 (NPS2)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Feasibility Study of the Ability of the Neural Prosthetic System 2 to Provide Direct Closed Loop Cortical Control of Extracorporeal Devices Through the Use of Intracortical Microstimulation in Patients With Quadriplegia
Record updated
23 October 2026